サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：細胞・遺伝子治療製造品質管理（QC）市場- 成長、将来展望、競合分析、2023年～2031年
市場調査レポート
商品コード
1422190

細胞・遺伝子治療製造品質管理（QC）市場- 成長、将来展望、競合分析、2023年～2031年

Cell And Gene Therapy Manufacturing Quality Control (QC) Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞・遺伝子治療製造品質管理（QC）市場- 成長、将来展望、競合分析、2023年～2031年
出版日: 2024年01月19日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞・遺伝子治療製造品質管理（QC）市場は、2024年から2032年の予測期間中にCAGR 25％で成長すると予測されています。細胞・遺伝子治療製造品質管理（QC）は、細胞・遺伝子治療の安全性、有効性、一貫性を確保する上で極めて重要な役割を果たします。細胞・遺伝子治療製造QC市場は、規制要件、個別化医療の動向、分析技術の進歩によって牽引されています。製品の特性評価が複雑であるにもかかわらず、細胞療法と遺伝子療法の採用が増加しているため、市場は成長する見込みです。機器・付属品およびプロセス開発分野は、予測期間中に大きな成長が見込まれます。地域的には、アジア太平洋に拡大のチャンスがあります。業界リーダーの戦略は、技術統合、生産能力拡大、包括的なQCソリューションに重点を置き、細胞・遺伝子治療製造品質管理の進化する要求に対応しています。

厳しい規制要件

細胞・遺伝子治療製造のQC市場は、FDAやEMAなどの保健当局が課す厳しい規制要件によって牽引されています。規制当局は、細胞治療や遺伝子治療が安全性と有効性の基準を満たしていることを保証するため、厳格な品質管理対策を求めています。例えば、FDAの化学・製造・管理（CMC）ガイドラインでは、治療の品質と一貫性を確保するために、徹底的な試験、特性評価、バリデーションが重視されています。規制状況は、QCインフラとテクノロジーへの投資の重要な推進力となっています。

個別化医療の普及

治療法を個々の患者に合わせてカスタマイズする個別化医療の台頭は、強固なQC手順への需要を高めています。細胞療法や遺伝子療法は患者ごとにカスタマイズされることが多く、正確な特性解析、同一性の確認、効力試験が必要とされます。細胞治療や遺伝子治療が主流になるにつれ、QC市場では、治療特有の品質と患者の安全性を確保するための高度な分析手法や技術に対する需要が急増しています。

分析技術の進歩

ハイスループット・シーケンス、質量分析、フローサイトメトリーなどの分析技術の急速な進歩は、QCの状況を一変させました。これらのテクノロジーは、遺伝子構成、純度、効力など、細胞治療や遺伝子治療の包括的な特性評価と分析を可能にします。最先端の分析をQCプロセスに統合することで、治療法の品質と信頼性が高まるだけでなく、開発・製造のタイムラインも短縮されます。

製品特性評価の複雑さ

細胞・遺伝子治療製造QC市場の主な抑制要因は、製品の特性解析の複雑さです。細胞治療や遺伝子治療は多面的で様々な成分を含むことが多く、包括的な特性評価が困難です。細胞集団、遺伝子改変、治療メカニズムの不均一性により、製品の品質を正確に評価できる高度な分析技術が必要となります。このような複雑さは、QC期間の長期化とコスト増につながる可能性があります。

コンポーネント別では消耗品が市場を独占

A市場はコンポーネント別に機器・付属品、消耗品、その他に区分されます。2023年には、消耗品が最も高い売上シェアを占めたが、これは主に細胞治療と遺伝子治療のQCプロセスにおける継続的な使用によるものです。2024年から2032年までの予測期間では、装置と付属品が最も高いCAGRを示すと予測されています。次世代シークエンサーや高速液体クロマトグラフィーシステムなど、先進的な機器や技術の採用がこの成長を牽引すると予測されます。

プロセス別ではダウンストリームプロセスが市場を独占

市場はさらにプロセス別に、アップストリームプロセス、ダウンストリームプロセス、プロセス開拓に区分されます。2023年には、ダウンストリームプロセスが最も高い収益を上げました。これは、治療用細胞や遺伝物質の精製・単離の必要性に起因します。しかし、予測期間中、プロセス開発が最も高いCAGRを達成すると予測されます。一貫した製品品質を確保するために製造プロセスの最適化とスケールアップに注力していることが、プロセス開発と関連QC戦略への投資を促進しています。

北米が世界のリーダーであり続ける

北米は、確立された細胞・遺伝子治療エコシステム、支持的な規制環境、重要な研究開発活動により、2023年に最も高い売上シェアを占めました。しかし、アジア太平洋地域は2024年から2032年にかけて最も高いCAGRを記録すると予測されています。ヘルスケアインフラへの投資の増加、研究協力の活発化、製造受託機関（CMO）の出現が、この地域のQC市場の成長を牽引しています。

市場競争は予測期間中に激化へ

細胞・遺伝子治療製造QC市場の有力企業には、Lonza Group、Charles River Laboratories、Eurofins Scientific、WuXiAppTec、bioMA（C）rieux SA、Bio-Rad Laboratories, Inc.、Bio-Techne Corporation、QIAGEN、Merck KGaA、Intertek Group plc、Thermo Fisher Scientific, Inc.、F. Hoffmann-La Roche Ltd.などがあります。これらの企業は、細胞・遺伝子治療特有の課題に合わせた幅広いQCサービス、分析ツール、専門知識を提供しています。主な戦略には、高度な分析技術への投資、検査能力の拡大、製品開発・製造・規制遵守をサポートする包括的なQCソリューションの提供などが含まれます。この市場の特徴は、進化するQCニーズに対応するための戦略的提携やパートナーシップです。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 細胞・遺伝子治療製造品質管理（QC）市場：競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2023 vs 2032

第4章 細胞・遺伝子治療製造品質管理（QC）市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の細胞・遺伝子治療製造品質管理（QC）市場金額 2022-2032
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済情勢
    • テクノロジーの情勢
    • 法的情勢
    • 社会的情勢

第5章 細胞・遺伝子治療製造品質管理（QC）市場：コンポーネント別 2022-2032

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 数量と価格の分析2022-2032
  • 市場セグメンテーション
    • 機器と付属品
    • 消耗品
    • その他

第6章 細胞・遺伝子治療製造品質管理（QC）市場：分析方法別 2022-2032

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 数量と価格の分析2022-2032
  • 市場セグメンテーション
    • 無菌試験
    • 純度試験
    • 効力試験
    • アイデンティティテスト
    • その他（安定性・生存性など）

第7章 細胞・遺伝子治療製造品質管理（QC）市場：プロセス別 2022-2032

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 数量と価格の分析2022-2032
  • 市場セグメンテーション
    • 上流工程
    • 下流工程
    • プロセス開発

第8章 細胞・遺伝子治療製造品質管理（QC）市場：エンドユーザー別 2022-2032

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 数量と価格の分析2022-2032
  • 市場セグメンテーション
    • 製薬およびバイオテクノロジー企業
    • 受託製造組織

第9章 北米の細胞・遺伝子治療製造品質管理（QC）市場 2022-2032

  • 市場概要
  • 細胞・遺伝子治療製造品質管理（QC）市場：コンポーネント別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：分析方法別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：プロセス別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：エンドユーザー別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：地域別 2022-2032
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第10章 英国と欧州連合の細胞・遺伝子治療製造品質管理（QC）市場 2022-2032

  • 市場概要
  • 細胞・遺伝子治療製造品質管理（QC）市場：コンポーネント別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：分析方法別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：プロセス別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：エンドユーザー別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：地域別 2022-2032
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第11章 アジア太平洋の細胞・遺伝子治療製造品質管理（QC）市場 2022-2032

  • 市場概要
  • 細胞・遺伝子治療製造品質管理（QC）市場：コンポーネント別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：分析方法別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：プロセス別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：エンドユーザー別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：地域別 2022-2032
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第12章 ラテンアメリカの細胞・遺伝子治療製造品質管理（QC）市場 2022-2032

  • 市場概要
  • 細胞・遺伝子治療製造品質管理（QC）市場：コンポーネント別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：分析方法別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：プロセス別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：エンドユーザー別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：地域別 2022-2032
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第13章 中東・アフリカの細胞・遺伝子治療製造品質管理（QC）市場 2022-2032

  • 市場概要
  • 細胞・遺伝子治療製造品質管理（QC）市場：コンポーネント別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：分析方法別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：プロセス別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：エンドユーザー別 2022-2032
  • 細胞・遺伝子治療製造品質管理（QC）市場：地域別 2022-2032
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第14章 企業プロファイル

  • Lonza Group
  • Charles River Laboratories
  • Eurofins Scientific
  • WuXiAppTec
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • QIAGEN
  • Merck KGaA
  • Intertek Group plc
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 2 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 3 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 4 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 5 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 6 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 7 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 8 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 9 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 10 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 11 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 12 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 13 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 14 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 15 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 16 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 17 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 19 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 20 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 21 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 23 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 24 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 25 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 26 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 27 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 28 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 29 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 30 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 31 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 32 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 33 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 34 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 35 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 36 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 37 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 38 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 39 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 40 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 41 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 42 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 43 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 44 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 45 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 47 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 48 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 49 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 50 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 51 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 52 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 53 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 54 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 55 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 56 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 57 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 58 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 59 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 60 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 61 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 62 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 63 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 64 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 65 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 66 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 67 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 68 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 69 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 70 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 71 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 72 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 73 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 74 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 75 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 76 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 77 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 78 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 79 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 80 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 81 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 82 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 83 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 84 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 85 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 87 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 88 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 89 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 91 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 92 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 93 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 94 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 95 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 96 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 97 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 98 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 99 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 100 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Quality Assurance
  • FIG. 5 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023
  • FIG. 6 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023
  • FIG. 7 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023
  • FIG. 8 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023
  • FIG. 9 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2023

FIG. 11Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Players, 2023

FIG. 12Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 13 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 Vs 2032, %
  • FIG. 14 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 Vs 2032, %
  • FIG. 15 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 Vs 2032, %
  • FIG. 16 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 Vs 2032, %
  • FIG. 17 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 24 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 26 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 28 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
目次
Product Code: 140079-01-24

The cell and gene therapy manufacturing quality control (QC) market is expected to grow at a CAGR of 25% during the forecast period of 2024 to 2032. Cell and gene therapy manufacturing quality control (QC)plays a pivotal role in ensuring the safety, efficacy, and consistency of cell and gene therapies. The cell and gene therapy manufacturing QC market is driven by regulatory requirements, personalized medicine trends, and advancements in analytical technologies. Despite the complexity of product characterization, the market is poised for growth due to the increasing adoption of cell and gene therapies. Equipment and accessories and Process Development segments are expected to exhibit significant growth during the forecast period. Geographically, Asia-Pacific presents opportunities for expansion. Industry leaders' strategies focus on technology integration, capacity expansion, and comprehensive QC solutions to address the evolving demands of cell and gene therapy manufacturing quality control.

Stringent Regulatory Requirements

The QC market for cell and gene therapy manufacturing is driven by stringent regulatory requirements imposed by health authorities such as the FDA and EMA. Regulatory agencies demand rigorous quality control measures to ensure that cell and gene therapies meet safety and efficacy standards. For example, the FDA's guidelines for chemistry, manufacturing, and controls (CMC) emphasize thorough testing, characterization, and validation to ensure the quality and consistency of therapies. The regulatory landscape serves as a significant driver for investments in QC infrastructure and technologies.

Growing Adoption of Personalized Medicine

The rise of personalized medicine, wherein therapies are tailored to individual patients, has amplified the demand for robust QC procedures. Cell and gene therapies are often customized for each patient, requiring precise characterization, identity confirmation, and potency testing. As cell and gene therapies become more mainstream, the QC market experiences a surge in demand for advanced analytical methods and technologies to ensure therapy-specific quality and patient safety.

Advancements in Analytical Technologies

Rapid advancements in analytical technologies, such as high-throughput sequencing, mass spectrometry, and flow cytometry, have revolutionized the QC landscape. These technologies enable comprehensive characterization and analysis of cell and gene therapies, including their genetic makeup, purity, and potency. The integration of cutting-edge analytics into QC processes not only enhances the quality and reliability of therapies but also expedites development and manufacturing timelines.

Complexity of Product Characterization

A key restraint in the cell and gene therapy manufacturing QC market is the complexity of product characterization. Cell and gene therapies are often multifaceted and involve various components, making their comprehensive characterization challenging. The heterogeneity of cell populations, genetic modifications, and therapeutic mechanisms necessitates advanced analytical techniques that can accurately assess product quality. This complexity can lead to prolonged QC timelines and increased costs.

Consumables Dominate the Market by Component

A The market is segmented by component into Equipment and accessories, Consumables, and Others. In 2023, Consumables accounted for the highest revenue share, primarily due to their continuous usage in cell and gene therapy QC processes. During the forecast period from 2024 to 2032, Equipment and accessories are projected to exhibit the highest CAGR. The adoption of advanced equipment and technologies, such as next-generation sequencers and high-performance liquid chromatography systems, is expected to drive this growth.

Downstream Processes Dominate the Market by Process

The market is further segmented by process into Upstream Processes, Downstream Processes, and Process Development. In 2023, Downstream Processes generated the highest revenue, attributed to the need for purification and isolation of therapeutic cells and genetic material. However, during the forecast period, Process Development is anticipated to achieve the highest CAGR. The focus on optimizing and scaling up manufacturing processes to ensure consistent product quality is driving investments in process development and associated QC strategies.

North America Remains as the Global Leader

North America held the highest revenue share in 2023, driven by its established cell and gene therapy ecosystem, supportive regulatory environment, and significant research and development activities. However, the Asia-Pacific region is projected to witness the highest CAGR from 2024 to 2032. Increasing investments in healthcare infrastructure, rising research collaborations, and the emergence of contract manufacturing organizations (CMOs) are driving the growth of the QC market in this region.

Market Competition to Intensify during the Forecast Period

Prominent players in the cell and gene therapy manufacturing QC market include Lonza Group, Charles River Laboratories, Eurofins Scientific, WuXiAppTec, bioMA©rieux SA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, QIAGEN, Merck KGaA, Intertek Group plc, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd. These companies provide a wide array of QC services, analytical tools, and expertise tailored to the unique challenges of cell and gene therapies. Key strategies involve investing in advanced analytical technologies, expanding testing capabilities, and offering comprehensive QC solutions that support product development, manufacturing, and regulatory compliance. The market is characterized by strategic collaborations and partnerships to address evolving QC needs.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofCell And Gene Therapy Manufacturing Quality Control (QC) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Cell And Gene Therapy Manufacturing Quality Control (QC) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Component

    • Equipment & Accessories
    • Consumables
    • Others

Analytical Method

    • Sterility Testing
    • Purity Testing
    • Potency Testing
    • Identity Testing
    • Others (stability, viability, etc.)

Process

    • Upstream Processes
    • Downstream Processes
    • Process Development

End-User

    • Pharmaceutical & Biotechnology Companies
    • Contract Manufacturing Organizations

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • Which is the largest regional market for Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cell And Gene Therapy Manufacturing Quality Control (QC) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cell And Gene Therapy Manufacturing Quality Control (QC) market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market
  • 2.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 (US$ Million)
  • 2.3. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 (US$ Million)
  • 2.4. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 (US$ Million)
  • 2.5. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 (US$ Million)
  • 2.6. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Competitive Analysis

  • 3.1. Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
  • 3.2. Strategies Adopted by Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Equipment & Accessories
    • 5.4.2. Consumables
    • 5.4.3. Others

6. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Sterility Testing
    • 6.4.2. Purity Testing
    • 6.4.3. Potency Testing
    • 6.4.4. Identity Testing
    • 6.4.5. Others (stability, viability, etc.)

7. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. Upstream Processes
    • 7.4.2. Downstream Processes
    • 7.4.3. Process Development

8. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Volume and Pricing Analysis, 2022-2032
  • 8.4. Market Segmentation
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Contract Manufacturing Organizations

9. North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 9.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 9.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 9.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 9.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

10. UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 10.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 10.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 10.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 10.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

11. Asia Pacific Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 11.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 11.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 11.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 11.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

12. Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 12.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 12.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 12.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 12.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

13. Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 13.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 13.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 13.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 13.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Lonza Group
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Charles River Laboratories
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Eurofins Scientific
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. WuXiAppTec
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. bioMerieux SA
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Bio-Rad Laboratories, Inc.
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Bio-Techne Corporation
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. QIAGEN
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Merck KGaA
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Intertek Group plc
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Thermo Fisher Scientific, Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. F. Hoffmann-La Roche Ltd.
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Other Notable Players
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives